当前位置: 首页 >> 检索结果
共有 360 条符合本次的查询结果, 用时 5.7611299 秒

321. Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review.

作者: Lillian Barra.;Janet Pope.;Louis Bessette.;Boulos Haraoui.;Vivian Bykerk.
来源: Rheumatology (Oxford). 2011年50卷2期311-6页
Serological markers are thought to be useful in predicting which patients with early inflammatory arthritis (EIA) will progress to RA. The objective of this study is to determine the per cent RF and anti-CCP seroconversion in EIA patients at 1-5 years of follow-up: 80% of established RA is RF or CCP positive.

322. The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis.

作者: Suzanne Lloyd.;Sylwia Bujkiewicz.;Allan J Wailoo.;Alex J Sutton.;David Scott.
来源: Rheumatology (Oxford). 2010年49卷12期2313-21页
To systematically review and meta-analyse evidence on the effectiveness of the TNF-α inhibitors when used sequentially.

323. Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review.

作者: Vijitha De Silva.;Ashraf El-Metwally.;Edzard Ernst.;George Lewith.;Gary J Macfarlane.; .
来源: Rheumatology (Oxford). 2010年49卷6期1063-8页
To critically evaluate the evidence regarding complementary and alternative medicines (CAMs) taken orally or applied topically for the treatment of FM.

324. Efficacy of acupuncture in fibromyalgia syndrome--a systematic review with a meta-analysis of controlled clinical trials.

作者: Jost Langhorst.;Petra Klose.;Frauke Musial.;Dominik Irnich.;Winfried Häuser.
来源: Rheumatology (Oxford). 2010年49卷4期778-88页
To systematically review the efficacy of acupuncture in fibromyalgia syndrome (FMS).

325. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

作者: Sarah L Westlake.;Alexandra N Colebatch.;Janis Baird.;Patrick Kiely.;Mark Quinn.;Ernest Choy.;Andrew J K Ostor.;Christopher J Edwards.
来源: Rheumatology (Oxford). 2010年49卷2期295-307页
Patients with RA have an increased prevalence of cardiovascular disease (CVD). This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA.

326. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature.

作者: Luca Garzoni.;Federica Vanoni.;Mattia Rizzi.;Giacomo D Simonetti.;Barbara Goeggel Simonetti.;Gian P Ramelli.;Mario G Bianchetti.
来源: Rheumatology (Oxford). 2009年48卷12期1524-9页
CNS or peripheral nervous system dysfunction sometimes occurs in Henoch-Schönlein patients.

327. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

作者: Christophe Meune.;Emmanuel Touzé.;Ludovic Trinquart.;Yannick Allanore.
来源: Rheumatology (Oxford). 2009年48卷10期1309-13页
RA is known to be associated with a high cardiovascular (CV) risk. Longitudinal data suggest that RA disease course may have become milder over the past decades. Thus, we set out to estimate the magnitude of the overall increase in CV mortality associated with RA and to determine whether it has decreased over the past 50 years.

328. (Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples.

作者: Ruby Knafo.;Brett D Thombs.;Lisa Jewett.;Marie Hudson.;Fred Wigley.;Jennifer A Haythornthwaite.
来源: Rheumatology (Oxford). 2009年48卷10期1300-3页
Sexual impairment in women with SSc has received little attention. The objective of this study was to compare levels of sexual impairment in women with SSc with samples of women with medical illnesses for which sexual impairment has been researched more extensively.

329. No clear association between female hormonal aspects and osteoarthritis of the hand, hip and knee: a systematic review.

作者: Bianca M de Klerk.;Dieuwke Schiphof.;Frans P M J Groeneveld.;Bart W Koes.;Gerjo J V M van Osch.;Joyce B J van Meurs.;Sita M A Bierma-Zeinstra.
来源: Rheumatology (Oxford). 2009年48卷9期1160-5页
Incidence of OA rises steeply in women of age >50 years; the climacteric period for women. The simultaneous occurrence of these events suggests an association between OA and changes in female hormonal aspects. This systematic review studies the assumed association between OA and aspects concerning the fertile period (duration, endogenous hormones, age at menarche/menopause) and the menopause [menopausal status, years since menopause (YSM) and surgical menopause].

330. Associations between work-related factors and specific disorders at the elbow: a systematic literature review.

作者: Rogier M van Rijn.;Bionka M A Huisstede.;Bart W Koes.;Alex Burdorf.
来源: Rheumatology (Oxford). 2009年48卷5期528-36页
To assess the exposure-response relationships between work-related physical and psychosocial factors and lateral epicondylitis, medial epicondylitis, cubital tunnel syndrome and radial tunnel syndrome in occupational populations.

331. Employment and work disability in systemic lupus erythematosus: a systematic review.

作者: Kim Baker.;Janet Pope.
来源: Rheumatology (Oxford). 2009年48卷3期281-4页
Many studies have provided information on employment and work disability (WD) rates in patients with SLE, yet are often limited by small sample sizes, poor generalizability or fail to examine the risks and outcomes of WD. Our objective was to systematically review the literature on WD in SLE to identify a more generalizable point estimate and range of WD in SLE patients.

332. Limited evidence for a protective effect of unopposed oestrogen therapy for osteoarthritis of the hip: a systematic review.

作者: B M de Klerk.;D Schiphof.;F P M J Groeneveld.;B W Koes.;G J V M van Osch.;J B J van Meurs.;S M A Bierma-Zeinstra.
来源: Rheumatology (Oxford). 2009年48卷2期104-12页
Above the age of 50 yrs, the incidence of OA rises steeply in women but less in men, suggesting an association with changes in female hormone levels in the menopause. This systematic review summarizes the evidence on the assumed association between exogenous hormone use and OA. Medline was searched up to March 2008 for articles assessing associations between OA of hand, hip or knee and menopause-related aspects. Methodological quality of the studies was assessed systematically. The results were summarized in a best-evidence synthesis. Nineteen studies on exogenous hormone use are included. Limited evidence was seen for a protective effect of unopposed oestrogen use for incidence of hip replacement/joint replacement, and a protective trend for incident radiological OA (ROA) of the knee. In prevalence studies, conflicting evidence was observed for hormone replacement therapy (HRT) use with DIP ROA and 'any joint OA', and oestrogen use with clinical knee OA. We found limited evidence for a significantly increased risk by using HRT for clinical hip OA and a significant protective effect of long-term unopposed oestrogen use for hip ROA. For all other relations studied no associations were found. Heterogeneity between the hormones used and outcome measurements made statistical data pooling impossible. The assumed relationship between the exogenous hormone use and OA was not clearly observed in this review. The relationship is perhaps too complex, or other aspects, yet to be determined, play a role in the increased incidence in women aged over 50 yrs. However, there is some evidence of a protective effect of unopposed oestrogen use for hip OA.

333. Acupuncture for rheumatoid arthritis: a systematic review.

作者: M S Lee.;B-C Shin.;E Ernst.
来源: Rheumatology (Oxford). 2008年47卷12期1747-53页
The aim of this systematic review is to evaluate the available evidence, from randomized clinical trials (RCTs), of acupuncture for treating patients with RA. Systematic searches were conducted on 17 databases up to April 2008 without the language restriction. All RCTs of acupuncture, with or without electrical stimulation or moxibustion, for patients with RA were considered for inclusion. A total of 236 potentially relevant studies were identified and eight RCTs were included. Four RCTs compared the effects of manual or electro-acupuncture with penetrating or non-penetrating sham acupuncture and failed to show specific effects of acupuncture on pain [n = 88; weighted mean differences (WMD), 10 cm VAS -0.46; 95% CI -1.70, 0.77; P = 0.46; heterogeneity: tau(2) = 0.19; chi(2) = 2.38; P = 0.30; I (2) = 16%] or other outcome measures. One RCT compared manual acupuncture with indomethacin and suggested favourable effects of acupuncture in terms of total response rate. Three RCTs tested acupuncture combined with moxibustion, vs conventional drugs and failed to show that acupuncture plus moxibustion was superior to conventional drugs in terms of response rate (n = 345; RR 1.12; 95% CI 0.99, 1.28; P = 0.08; heterogeneity: tau(2) = 0.00; chi(2) = 1.34; P = 0.51; I(2) = 0%), pain reduction (n = 105; WMD, 10 cm VAS 1.53; 95% CI -0.57, 3.63; P = 0.15; heterogeneity: tau(2) = 1.18; chi(2) = 1.81; P = 0.18; I(2) = 45%) or joint swelling index (n = 105; WMD, 10 cm VAS 0.25; 95% CI -1.31, 1.82; P = 0.75; heterogeneity: tau(2) = 0.18;chi(2) = 1.14; P = 0.28; I(2) = 13%). In conclusion, penetrating or non-penetrating sham-controlled RCTs failed to show specific effects of acupuncture for pain control in patients with RA. More rigorous research seems to be warranted.

334. A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples.

作者: B D Thombs.;M Bassel.;L McGuire.;M T Smith.;M Hudson.;J A Haythornthwaite.
来源: Rheumatology (Oxford). 2008年47卷10期1559-63页
There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively.

335. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy.

作者: B Nishishinya.;G Urrútia.;B Walitt.;A Rodriguez.;X Bonfill.;C Alegre.;G Darko.
来源: Rheumatology (Oxford). 2008年47卷12期1741-6页
The objective of this study was to assess the efficacy and safety of amitriptyline as a treatment of FM. A comprehensive computerized search in Medline (Pubmed), EMBASE and The Cochrane Library was performed. Randomized controlled trials (RCTs) comparing amitriptyline vs placebo in adult patients suffering from FM were identified, the methodological quality was assessed and the results of the main outcomes were evaluated. Ten RCTs were identified. Large clinical variability and statistical heterogeneity precluded quantitative meta-analysis. Overall, the study quality was moderate to high. Amitriptyline 25 mg/day (six RCTs) demonstrated a therapeutic response compared with placebo in the domains of pain, sleep, fatigue and overall patient and investigator impression. This benefit was generally seen at 6-8 weeks of treatment but no effect was noted at 12 weeks. Amitriptyline 50 mg/day (four RCTs) did not demonstrate a therapeutic effect compared with placebo. Neither dose of amitriptyline had an effect on tender points count. No clear statements on adverse events with amitriptyline can be made due to inconsistencies in data among the studies. A definitive clinical recommendation regarding the efficacy of amitriptyline for FM symptoms cannot be made. There is some evidence to support the short-term efficacy of amitriptyline 25 mg/day in FM. There is no evidence to support the efficacy of amitriptyline at higher doses or for periods >8 weeks. More stringent RCTs with longer follow-up periods are required to determine the long-term efficacy and safety of the amitriptyline and define its role in the multidisciplinary management of FM.

336. Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies.

作者: S Perrot.;R-M Javier.;M Marty.;C Le Jeunne.;F Laroche.; .
来源: Rheumatology (Oxford). 2008年47卷8期1117-23页
The aim of this study was to review the evidence supporting the use of anti-depressants in painful rheumatological conditions. A systematic review of papers published between 1966 and 2007, in five European languages, on anti-depressants in rheumatological conditions was performed. Papers were scored using Jadad method and analgesic ES was calculated. We selected 78 clinical studies and 12 meta-analyses, from 140 papers. The strongest evidence of an analgesic effect of anti-depressants has been obtained for fibromyalgia. A weak analgesic effect is observed for chronic low back pain, with an efficacy level close to that of analgesics. In RA and AS, there is no analgesic effect of anti-depressants, but these drugs may help to manage fatigue and sleep disorders. There is no clear evidence of an analgesic effect inOA, but studies have poor methodological quality. Analgesic effects of anti-depressants are independent of their anti-depressant effects. Tricyclic anti-depressants (TCAs), even at low doses, have analgesic effects equivalent to those of serotonin and noradrenalin reuptake inhibitors (SNRIs), but are less well tolerated. Selective serotonin reuptake inhibitors (SSRIs) have modest analgesic effects, but higher doses are required to achieve analgesia. Anti-depressant drugs, particularly TCAs and SNRIs, have analgesic effects in chronic rheumatic painful states in which analgesics and NSAIDs are not very efficient, such as fibromyalgia and chronic low back pain. In inflammatory rheumatic diseases, anti-depressants may be useful for managing fatigue and sleep disorders. Further studies are required to compare anti-depressants with other analgesics in the management of chronic painful rheumatological conditions.

337. Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes.

作者: L Scascighini.;V Toma.;S Dober-Spielmann.;H Sprott.
来源: Rheumatology (Oxford). 2008年47卷5期670-8页
To provide an overview of the effectiveness of multidisciplinary treatments of chronic pain and investigate about their differential effects on outcome in various pain conditions and of different multidisciplinary treatments, settings or durations.

338. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.

作者: G S Metsios.;A Stavropoulos-Kalinoglou.;J J C S Veldhuijzen van Zanten.;G J Treharne.;V F Panoulas.;K M J Douglas.;Y Koutedakis.;G D Kitas.
来源: Rheumatology (Oxford). 2008年47卷3期239-48页
This systematic review investigates the effectiveness of exercise interventions in improving disease-related characteristics in patients with rheumatoid arthritis (RA). It also provides suggestions for exercise programmes suitable for improving the cardiovascular profile of RA patients and proposes areas for future research in the field. Six databases (Medline, Cochrane Library, CINAHL, Google Scholar, EMBASE and PEDro) were searched to identify publications from 1974 to December 2006 regarding RA and exercise interventions. The quality of the studies included was determined by using the Jadad scale. Initial searches identified 1342 articles from which 40 met the inclusion criteria. No studies were found investigating exercise interventions in relation to cardiovascular disease in RA. There is strong evidence suggesting that exercise from low to high intensity of various modes is effective in improving disease-related characteristics and functional ability in RA patients. Future studies are required to investigate the effects of exercise in improving the cardiovascular status of this patient population.

339. The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.

作者: Y Bravo Vergel.;N S Hawkins.;K Claxton.;C Asseburg.;S Palmer.;N Woolacott.;I N Bruce.;M J Sculpher.
来源: Rheumatology (Oxford). 2007年46卷11期1729-35页
Tumour necrosis factor (TNF) antagonists have been shown to improve the outcomes in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). We assess the cost-effectiveness of two TNF antagonists and so-called 'palliative care' for the treatment of active PsA from the perspective of the UK National Health Service (NHS).

340. Tai chi for rheumatoid arthritis: systematic review.

作者: M S Lee.;M H Pittler.;E Ernst.
来源: Rheumatology (Oxford). 2007年46卷11期1648-51页
The objective of this systematic review is to evaluate data from controlled clinical trials testing the effectiveness of tai chi for treating rheumatoid arthritis (RA). Systematic searches were conducted on Medline, Pubmed, AMED, British Nursing Index, CINAHL, EMBASE, PsycInfo, The Cochrane Library 2007, Issue 1, the UK National Research Register and ClinicalTrials.gov, Korean medical databases, Qigong and Energy Medicine Database and Chinese databases up to January 2007. Hand-searches included conference proceedings and our own files. There were no restrictions regarding the language of publication. All controlled trials of tai chi for patients with RA were considered for inclusion. Methodological quality was assessed using the Jadad score. The searches identified 45 potentially relevant studies. Two randomized clinical trials (RCTs) and three non-randomized controlled clinical trials (CCTs) met all inclusion criteria. The included RCTs reported some positive findings for tai chi on disability index, quality of life, depression and mood for RA patients. Two RCTs assessed pain outcomes and did not demonstrate effectiveness on pain reduction compared with education plus stretching exercise and usual activity control. The extent of heterogeneity in these RCTs prevented a meaningful meta-analysis. Currently there are few trials testing the effectiveness of tai chi in the management of RA. The studies that are available are of low methodological quality. Collectively this evidence is not convincing enough to suggest that tai chi is an effective treatment for RA. The value of tai chi for this indication therefore remains unproven.
共有 360 条符合本次的查询结果, 用时 5.7611299 秒